CN102851394B - 一种检测肠道病毒71型rna的方法及试剂盒 - Google Patents
一种检测肠道病毒71型rna的方法及试剂盒 Download PDFInfo
- Publication number
- CN102851394B CN102851394B CN201210315436.0A CN201210315436A CN102851394B CN 102851394 B CN102851394 B CN 102851394B CN 201210315436 A CN201210315436 A CN 201210315436A CN 102851394 B CN102851394 B CN 102851394B
- Authority
- CN
- China
- Prior art keywords
- rna
- solution
- test kit
- probe
- detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241001529459 Enterovirus A71 Species 0.000 title claims abstract description 70
- 238000000034 method Methods 0.000 title abstract description 40
- 238000001514 detection method Methods 0.000 title abstract description 39
- 239000000523 sample Substances 0.000 claims abstract description 60
- 239000011324 bead Substances 0.000 claims abstract description 33
- 230000005291 magnetic effect Effects 0.000 claims abstract description 33
- 238000006243 chemical reaction Methods 0.000 claims abstract description 20
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 19
- 108091033319 polynucleotide Proteins 0.000 claims abstract description 18
- 102000040430 polynucleotide Human genes 0.000 claims abstract description 18
- 239000002157 polynucleotide Substances 0.000 claims abstract description 18
- 230000003321 amplification Effects 0.000 claims abstract description 15
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 15
- 239000000243 solution Substances 0.000 claims description 51
- 238000012360 testing method Methods 0.000 claims description 31
- 239000000284 extract Substances 0.000 claims description 30
- 108090000790 Enzymes Proteins 0.000 claims description 13
- 102000004190 Enzymes Human genes 0.000 claims description 13
- 241000700605 Viruses Species 0.000 claims description 11
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 claims description 11
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 239000013642 negative control Substances 0.000 claims description 9
- 239000013641 positive control Substances 0.000 claims description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 7
- DBLXOVFQHHSKRC-UHFFFAOYSA-N ethanesulfonic acid;2-piperazin-1-ylethanol Chemical compound CCS(O)(=O)=O.OCCN1CCNCC1 DBLXOVFQHHSKRC-UHFFFAOYSA-N 0.000 claims description 6
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 claims description 6
- 239000011535 reaction buffer Substances 0.000 claims description 6
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 5
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 5
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 5
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical group [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 5
- 239000004141 Sodium laurylsulphate Substances 0.000 claims description 5
- 239000005549 deoxyribonucleoside Substances 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 5
- 239000001226 triphosphate Substances 0.000 claims description 5
- 235000011178 triphosphate Nutrition 0.000 claims description 5
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 claims description 5
- 239000002480 mineral oil Substances 0.000 claims description 4
- 235000010446 mineral oil Nutrition 0.000 claims description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 3
- 239000013612 plasmid Substances 0.000 claims description 3
- 238000003780 insertion Methods 0.000 claims description 2
- 230000037431 insertion Effects 0.000 claims description 2
- 102000039446 nucleic acids Human genes 0.000 abstract description 14
- 108020004707 nucleic acids Proteins 0.000 abstract description 14
- 150000007523 nucleic acids Chemical class 0.000 abstract description 14
- 230000035945 sensitivity Effects 0.000 abstract description 11
- 238000000605 extraction Methods 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 6
- 230000005298 paramagnetic effect Effects 0.000 abstract description 6
- 239000002245 particle Substances 0.000 abstract description 6
- 238000000746 purification Methods 0.000 abstract description 5
- 238000001179 sorption measurement Methods 0.000 abstract description 2
- 238000002123 RNA extraction Methods 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 56
- 239000012925 reference material Substances 0.000 description 15
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- 238000003753 real-time PCR Methods 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 230000009514 concussion Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241001429382 Coxsackievirus A16 Species 0.000 description 2
- 241000701022 Cytomegalovirus Species 0.000 description 2
- 241000709661 Enterovirus Species 0.000 description 2
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 2
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000202921 Ureaplasma urealyticum Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000013399 early diagnosis Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000002101 lytic effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 238000002205 phenol-chloroform extraction Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000003196 chaotropic effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
- 238000000703 high-speed centrifugation Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 230000036963 noncompetitive effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000013615 primer Substances 0.000 description 1
- 239000002987 primer (paints) Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
物料名称 | 单人份用量 |
引物EV71-F1(50pmol/μl) | 0.2μl |
引物EV71-R1(50pmol/μl) | 0.2μl |
探针EV71-P1(50pmol/μl) | 0.1μl |
内标引物dzu-F1(40pmol/μl) | 0.2μl |
内标引物dzu-R1(40pmol/μl) | 0.2μl |
内标探针dzu-P1(50pmol/μl) | 0.06μl |
dNTPs | 0.8μl |
5×PCR buffer | 10μl |
灭菌纯化水 | 31.24μl |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210315436.0A CN102851394B (zh) | 2012-08-30 | 2012-08-30 | 一种检测肠道病毒71型rna的方法及试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210315436.0A CN102851394B (zh) | 2012-08-30 | 2012-08-30 | 一种检测肠道病毒71型rna的方法及试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102851394A CN102851394A (zh) | 2013-01-02 |
CN102851394B true CN102851394B (zh) | 2014-01-15 |
Family
ID=47398368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210315436.0A Active CN102851394B (zh) | 2012-08-30 | 2012-08-30 | 一种检测肠道病毒71型rna的方法及试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102851394B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104846122A (zh) * | 2015-05-13 | 2015-08-19 | 宝瑞源生物技术(北京)有限公司 | 肠道病毒71型和柯萨奇病毒a16型核酸检测试剂盒(荧光pcr法) |
CN104928402B (zh) * | 2015-06-15 | 2018-03-27 | 菲鹏生物股份有限公司 | 荧光定量pcr检测核酸分子的方法 |
CN108823200B (zh) * | 2018-07-11 | 2020-06-19 | 广州海力特生物科技有限公司 | 一种病原体dna核酸释放剂 |
CN110804608A (zh) * | 2018-08-06 | 2020-02-18 | 绍兴迅敏康生物科技有限公司 | 一种用于磁棒进行磁珠吸附的试剂以及方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012060779A1 (en) * | 2010-11-02 | 2012-05-10 | Singapore Polytechnic | Method for detection of enterovirus ev71 |
CN102643927A (zh) * | 2011-02-21 | 2012-08-22 | 刘志学 | 手足口病检测试剂盒及其检测方法 |
CN102154510B (zh) * | 2011-02-25 | 2013-01-16 | 湖南圣湘生物科技有限公司 | 丙型肝炎病毒核酸定量检测试剂盒 |
CN102559924B (zh) * | 2011-04-20 | 2013-08-21 | 深圳国际旅行卫生保健中心 | 手足口病EV71病毒real-time RT-PCR检测试剂盒及其非诊断检测方法 |
CN102559939B (zh) * | 2012-03-29 | 2013-11-27 | 东南大学 | 鉴别71型和非71型肠道病毒的单管二重一步法rt-pcr引物及其应用 |
-
2012
- 2012-08-30 CN CN201210315436.0A patent/CN102851394B/zh active Active
Non-Patent Citations (2)
Title |
---|
周世力等.肠道病毒71型的研究进展.《病毒学报》.2003,第19卷(第3期),全文. |
肠道病毒71型的研究进展;周世力等;《病毒学报》;20030930;第19卷(第3期);全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN102851394A (zh) | 2013-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103725799B (zh) | 一种检测风疹病毒rna的方法及试剂盒 | |
CN101701267B (zh) | 乙型肝炎病毒荧光定量pcr检测试剂盒及其应用 | |
CN103642941B (zh) | 一种乙型肝炎病毒(hbv)核酸定量检测试剂盒 | |
CN102154510B (zh) | 丙型肝炎病毒核酸定量检测试剂盒 | |
CN104342503B (zh) | 一种同时检测12种常见呼吸道病毒的方法 | |
CN103060451B (zh) | 一种肺炎支原体mp检测试剂盒 | |
CN103060473B (zh) | 一种疱疹类病毒ebv检测试剂盒 | |
CN102140558A (zh) | 一种定量检测乙型肝炎病毒(hbv)的方法及其试剂盒 | |
Ulloa et al. | A simple method for SARS-CoV-2 detection by rRT-PCR without the use of a commercial RNA extraction kit | |
CN102851394B (zh) | 一种检测肠道病毒71型rna的方法及试剂盒 | |
CN104846122A (zh) | 肠道病毒71型和柯萨奇病毒a16型核酸检测试剂盒(荧光pcr法) | |
CN101760560A (zh) | 一种人巨细胞病毒(hcmv)荧光pcr检测方法 | |
CN103757139A (zh) | 犬瘟热、犬细小病毒二重TaqMan MGB荧光定量PCR检测试剂及其检测方法 | |
CN101550455B (zh) | 人副流感病毒分型及定量检测试剂盒 | |
CN105648059A (zh) | 一种基于rpa的日本血吸虫核酸检测试剂盒及检测方法 | |
CN103710464B (zh) | 一种丙型肝炎病毒基因型检测试剂盒 | |
CN101538619A (zh) | 一种戊型肝炎病毒rna检测试剂盒 | |
CN101550452B (zh) | 人博卡病毒实时荧光pcr检测试剂盒 | |
CN105420411A (zh) | 一种肠道病毒通用型、柯萨奇病毒a16型、肠道病毒71型核酸荧光pcr检测试剂盒 | |
CN105177181A (zh) | 检测乙型肝炎病毒的引物对和荧光探针及试剂盒 | |
CN105779644B (zh) | 人巨细胞病毒的实时荧光核酸恒温扩增检测试剂盒 | |
CN105296676A (zh) | 一种戊型肝炎病毒荧光定量pcr检测试剂盒及其使用方法 | |
CN112899398A (zh) | 一种非洲猪瘟病毒的荧光pcr检测试剂盒及其使用方法 | |
CN104328216A (zh) | 一种埃博拉病毒快速分型鉴别检测试剂盒 | |
CN102816867B (zh) | 一种检测柯萨奇病毒a16型rna的方法及试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HUNAN SHENGWEIER MEDICAL INSPECTION CO., LTD. Free format text: FORMER OWNER: HUNAN SHENGXIANG BIOLOGICAL TECHNOLOGY CO., LTD. Effective date: 20141119 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20141119 Address after: 410012, No. 680, Lu Song Road, Changsha hi tech Development Zone, Hunan Patentee after: Hunan company limited of Sheng Weier medical test institute Address before: 410012 No. 198 west slope, Tongzi hi tech Industrial Development Zone, Hunan, Changsha Patentee before: Sansure Biotech Inc. |
|
ASS | Succession or assignment of patent right |
Owner name: HUNAN SHENGXIANG BIOLOGICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: HUNAN SHENGWEIER MEDICAL INSPECTION CO., LTD. Effective date: 20150526 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150526 Address after: 410012, No. 680, Lu Song Road, hi tech Development Zone, Hunan, Changsha Patentee after: Sansure Biotech Inc. Address before: 410012, No. 680, Lu Song Road, Changsha hi tech Development Zone, Hunan Patentee before: Hunan company limited of Sheng Weier medical test institute |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method and kit for detection of human enterovirus 71 RNA Effective date of registration: 20170711 Granted publication date: 20140115 Pledgee: Ningbo free trade zone Terry with equity investment partnership (limited partnership)|Suzhou equity equity investment center (limited partnership)|Ningbo Meishan Bonded Port District, Jun and equity investment partnership (limited partnership)|Chen Bang Pledgor: Hunan Gene Technology Co.|Hunan San Xiang Biological Technology Co. Ltd. Registration number: 2017430000042 |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 410012, No. 680, Lu Song Road, hi tech Development Zone, Hunan, Changsha Patentee after: Shengxiang Biotechnology Co., Ltd Address before: 410012, No. 680, Lu Song Road, hi tech Development Zone, Hunan, Changsha Patentee before: Sansure Biotech Inc. |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200217 Granted publication date: 20140115 Pledgee: Suzhou Lirui equity investment center (limited partnership)|Triton equity investment partnership (limited partnership)|JUNHE Tongrui equity investment partnership (limited partnership)|Chenbang Pledgor: SANSURE BIOTECH Inc. Registration number: 2017430000042 |